Stanley Cryz

496 total citations
11 papers, 370 citations indexed

About

Stanley Cryz is a scholar working on Infectious Diseases, Cardiology and Cardiovascular Medicine and Animal Science and Zoology. According to data from OpenAlex, Stanley Cryz has authored 11 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 6 papers in Cardiology and Cardiovascular Medicine and 3 papers in Animal Science and Zoology. Recurrent topics in Stanley Cryz's work include Viral gastroenteritis research and epidemiology (8 papers), Viral Infections and Immunology Research (6 papers) and Animal Virus Infections Studies (3 papers). Stanley Cryz is often cited by papers focused on Viral gastroenteritis research and epidemiology (8 papers), Viral Infections and Immunology Research (6 papers) and Animal Virus Infections Studies (3 papers). Stanley Cryz collaborates with scholars based in United States, South Africa and Chile. Stanley Cryz's co-authors include Alan Fix, Len Dally, Jorge Flores, Monica McNeal, Maureen Power, Anthonet Koen, Iksung Cho, Lisa Jose, Shabir A. Madhi and Nicola Page and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Infectious Diseases and The Lancet Infectious Diseases.

In The Last Decade

Stanley Cryz

11 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stanley Cryz United States 8 281 161 121 91 78 11 370
Marcelo H. Argüelles Argentina 11 285 1.0× 165 1.0× 97 0.8× 95 1.0× 10 0.1× 16 343
Semi Rho South Korea 11 221 0.8× 114 0.7× 163 1.3× 30 0.3× 43 0.6× 19 335
Robert R. Goodwin United States 8 502 1.8× 267 1.7× 204 1.7× 90 1.0× 22 0.3× 8 526
Yaoska Reyes Nicaragua 11 405 1.4× 173 1.1× 121 1.0× 92 1.0× 10 0.1× 31 431
Jill Barrett United States 4 230 0.8× 102 0.6× 76 0.6× 48 0.5× 11 0.1× 5 243
Fredman González Nicaragua 9 266 0.9× 120 0.7× 78 0.6× 59 0.6× 8 0.1× 27 285
E. Lebacq Belgium 9 174 0.6× 77 0.5× 46 0.4× 78 0.9× 14 0.2× 13 351
S Aspinall South Africa 10 247 0.9× 143 0.9× 74 0.6× 208 2.3× 7 0.1× 24 387
AlbertZ. Kapikian United States 6 422 1.5× 125 0.8× 155 1.3× 143 1.6× 25 0.3× 6 501
Gökçe Günaydın Sweden 8 241 0.9× 91 0.6× 81 0.7× 67 0.7× 33 0.4× 11 353

Countries citing papers authored by Stanley Cryz

Since Specialization
Citations

This map shows the geographic impact of Stanley Cryz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanley Cryz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanley Cryz more than expected).

Fields of papers citing papers by Stanley Cryz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stanley Cryz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanley Cryz. The network helps show where Stanley Cryz may publish in the future.

Co-authorship network of co-authors of Stanley Cryz

This figure shows the co-authorship network connecting the top 25 collaborators of Stanley Cryz. A scholar is included among the top collaborators of Stanley Cryz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stanley Cryz. Stanley Cryz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
2.
Groome, Michelle J., Lee Fairlie, Julie Morrison, et al.. (2020). Safety and immunogenicity of a parenteral trivalent P2-VP8 subunit rotavirus vaccine: a multisite, randomised, double-blind, placebo-controlled trial. The Lancet Infectious Diseases. 20(7). 851–863. 61 indexed citations
3.
Agarwal, Sanjeev, John M. Hickey, George A. Robertson, et al.. (2019). Characterizing and Minimizing Aggregation and Particle Formation of Three Recombinant Fusion-Protein Bulk Antigens for Use in a Candidate Trivalent Rotavirus Vaccine. Journal of Pharmaceutical Sciences. 109(1). 394–406. 13 indexed citations
4.
Agarwal, Sanjeev, John M. Hickey, Ronald Toth, et al.. (2019). Recombinant Subunit Rotavirus Trivalent Vaccine Candidate: Physicochemical Comparisons and Stability Evaluations of Three Protein Antigens. Journal of Pharmaceutical Sciences. 109(1). 380–393. 15 indexed citations
5.
Agarwal, Sanjeev, John M. Hickey, David McAdams, et al.. (2019). Effect of Aluminum Adjuvant and Preservatives on Structural Integrity and Physicochemical Stability Profiles of Three Recombinant Subunit Rotavirus Vaccine Antigens. Journal of Pharmaceutical Sciences. 109(1). 476–487. 25 indexed citations
6.
Koen, Anthonet, Lisa Jose, Shabir A. Madhi, et al.. (2019). Neutrophil Counts in Healthy South African Infants: Implications for Enrollment and Adverse Event Grading in Clinical Trials in an African Setting. SHILAP Revista de lepidopterología. 1. 100005–100005. 3 indexed citations
7.
Hickey, John M., Sangeeta B. Joshi, David B. Volkin, et al.. (2018). Formulation development of a recombinant protein based non-replicating rotavirus (NRRV) vaccine candidate: Antigen-adjuvant-preservative interactions. 1 indexed citations
8.
Groome, Michelle J., Anthonet Koen, Alan Fix, et al.. (2017). Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial. The Lancet Infectious Diseases. 17(8). 843–853. 102 indexed citations
9.
Fix, Alan, Clayton Harro, Monica McNeal, et al.. (2015). Safety and immunogenicity of a parenterally administered rotavirus VP8 subunit vaccine in healthy adults. Vaccine. 33(31). 3766–3772. 52 indexed citations
10.
Lagos, Rosanna, I Horwitz, V Prado, et al.. (1993). [Tolerance and immunogenicity of an oral dose of CVD 103-HgR, a live attenuated Vibrio cholerae 01 strain: a double-blind study of Chilean adults].. PubMed. 121(8). 857–63. 15 indexed citations
11.
Hoge, Charles W., Andrew F. Trofa, S Migasena, et al.. (1992). Safety and Immunogenicity of Different Immunization Regimens of CVD 103-HgR Live Oral Cholera Vaccine in Soldiers and Civilians in Thailand. The Journal of Infectious Diseases. 165(6). 1042–1048. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcelo H. Argüelles Breakdown of academic impact, for papers by Semi Rho Breakdown of academic impact, for papers by Robert R. Goodwin Breakdown of academic impact, for papers by Yaoska Reyes Breakdown of academic impact, for papers by Jill Barrett Breakdown of academic impact, for papers by Fredman González Breakdown of academic impact, for papers by E. Lebacq Breakdown of academic impact, for papers by S Aspinall Breakdown of academic impact, for papers by AlbertZ. Kapikian Breakdown of academic impact, for papers by Gökçe Günaydın
Rankless by CCL
2026